<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="308114">
  <stage>Registered</stage>
  <submitdate>24/06/2009</submitdate>
  <approvaldate>8/07/2009</approvaldate>
  <actrnumber>ACTRN12609000552280</actrnumber>
  <trial_identification>
    <studytitle>Patient satisfaction following total hip arthroplasty for osteoarthritis: a randomised controlled trial of the lateral and posterior approaches.</studytitle>
    <scientifictitle>Patient satisfaction following total hip arthroplasty for osteoarthritis: a randomised controlled trial of the lateral and posterior approaches.</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>1.2</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Total hip arthroplasty for osteoarthritis</healthcondition>
    <conditioncode>
      <conditioncode1>Surgery</conditioncode1>
      <conditioncode2>Surgical techniques</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Lateral approach to the hip

Division of fascia lata, subperiosteal dissection of anterior 1/3 of gluteus medius and origin of vastus lateralis, capsulotomy; total hip arthroplasty in the standard manner, repair of gluteus medius flap with 2 vicryl, duration of entire procedure approximately 90 minutes</interventions>
    <comparator>Posterior approach to the hip
Division of fascia lata/gluteus maximus, elevation of short external rotators from lateral insertion, capsulotomy, total hip arthroplasty in the standard manner, short external rotator repair with non-absorbable suture, total duration of procedure ~90 minutes</comparator>
    <control>Active</control>
    <interventioncode>Treatment: surgery</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Patient satisfaction as assessed by visual analogue pain score, Oxford hip score, Short Form-36 and Western Ontario and McMaster University Index</outcome>
      <timepoint>Assessment of the above at 6 weeks, 3 months, 6 months, 1 year post-operatively.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Prevalence of trochanteric bursitis as defined by at least 2 of the following 3: (i) lateral hip pain with a pain score of 3/10 or more (ii) lateral hip tenderness (iii) response to steroid injection as assessed by history and examination at a clinic appointment (at 6 months and 1 year, or more often if symptoms necessitate)</outcome>
      <timepoint>6 months, 1 year post-operatively</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Osteoarthritis of the hip</inclusivecriteria>
    <inclusiveminage>0</inclusiveminage>
    <inclusiveminagetype>No limit</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Fracture neck of femur Malignancy affecting the hip Previous hip surgery Dementia hip anatomy incompatible with chosen implants on pre-operative templating</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Patients with a diagnosis of hip osteoarthitis requiring total hip arthroplasty and who do not have exclusion criteria will be offered participation in the trial, with the uncertainty regarding the best approach outlined. Consenting patients will be randomised to either the lateral or posterior approach on the day of operation. The patient will remain blinded; the surgical team will perform the lateral or posterior approach based on the contents of a sealed envelope.</concealment>
    <sequence>Chronologically</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Safety/efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>15/04/2010</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>302</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry />
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state />
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>Whangarei Hospital</primarysponsorname>
    <primarysponsoraddress>Maunu Rd
PO Box 9742
Whangarei 0110</primarysponsoraddress>
    <primarysponsorcountry>New Zealand</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Charities/Societies/Foundations</fundingtype>
      <fundingname>N/A</fundingname>
      <fundingaddress>Wishbone Trust
c/- Sue Johnston
PO Box 7451
Wellington South 6011</fundingaddress>
      <fundingcountry>New Zealand</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
    <othercollaborator>
      <othercollaboratortype>Individual</othercollaboratortype>
      <othercollaboratorname>Mr. R. Coup</othercollaboratorname>
      <othercollaboratoraddress>Whangarei Hospital
Maunu Rd
PO Box 9742
Whangarei 0110</othercollaboratoraddress>
      <othercollaboratorcountry>New Zealand</othercollaboratorcountry>
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Patient satisfaction following total hip arthroplasty for osteoarthritis: a randomised controlled trial of the lateral and posterior approaches.</summary>
    <trialwebsite>N/A</trialwebsite>
    <publication>N/A</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Northern Y Regional Ethics Committee</ethicname>
      <ethicaddress>Ministry of Health
PO Box 1031 
354 Victoria Street
Hamilton
New Zealand</ethicaddress>
      <ethicapprovaldate>14/04/2010</ethicapprovaldate>
      <hrec>NTY/10/01/002</hrec>
      <ethicsubmitdate>31/07/2009</ethicsubmitdate>
      <ethiccountry>New Zealand</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Jonathan Manson</name>
      <address>Orthopaedic Department
PO Box 742
Maunu Road
Whangarei
New Zealand</address>
      <phone>0064 09 430 4100</phone>
      <fax />
      <email>the.royal.ears@gmail.com</email>
      <country>New Zealand</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Jonathan Manson</name>
      <address>Orthopaedic Department
PO Box 742
Maunu Road
Whangarei
New Zealand</address>
      <phone>0064 09 430 4100</phone>
      <fax />
      <email>the.royal.ears@gmail.com</email>
      <country>New Zealand</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Jonathan Manson</name>
      <address>Orthopaedic Department
PO Box 742
Maunu Road
Whangarei
New Zealand</address>
      <phone />
      <fax />
      <email>the.royal.ears@gmail.com</email>
      <country>New Zealand</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>